Screen Shot 2023-08-15 at 11.52.48 AM
Blog - Latest News
You are here: Home1 / Efficacy of National Comprehensive Cancer Network Guidelines in Identifying Pathogenic Germline Variants Among Unselected Patients with Prostate Cancer: The PROCLAIM Trial2 / Screen Shot 2023-08-15 at 11.52.48 AM
Contact
Carolina Urologic Research Center
823 82nd Parkway, Suite B
Myrtle Beach, SC 29572
Phone: (843) 839-1679
Fax: (843) 286-0119
Email:
info@curcmb.com
Recent Happenings
- START Further Expands Its Global Oncology Site Network with the Addition of Carolina Urologic Research Center
- Final Version: Expert Consensus Recommendations on the Management of Treatment-emergent Adverse Events Among Men with Prostate Cancer Taking Poly-ADP Ribose Polymerase Inhibitor + Novel Hormonal Therapy Combination Therapy
- The landscape of androgen deprivation therapies for the treatment of advanced prostate cancer
- Advances in Prostate Cancer Care: Genetic Testing, Teamwork, and ARPIs
Our Affiliates
Leave a Reply
Want to join the discussion?Feel free to contribute!